IBDEI1W7 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30228,1,3,0)
 ;;=3^Hallucinogen Induced Bipolar D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,30228,1,4,0)
 ;;=4^F16.14
 ;;^UTILITY(U,$J,358.3,30228,2)
 ;;=^5003328
 ;;^UTILITY(U,$J,358.3,30229,0)
 ;;=F16.24^^120^1540^5
 ;;^UTILITY(U,$J,358.3,30229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30229,1,3,0)
 ;;=3^Hallucinogen Induced Bipolar D/O w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,30229,1,4,0)
 ;;=4^F16.24
 ;;^UTILITY(U,$J,358.3,30229,2)
 ;;=^5003341
 ;;^UTILITY(U,$J,358.3,30230,0)
 ;;=F16.94^^120^1540^6
 ;;^UTILITY(U,$J,358.3,30230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30230,1,3,0)
 ;;=3^Hallucinogen Induced Bipolar D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,30230,1,4,0)
 ;;=4^F16.94
 ;;^UTILITY(U,$J,358.3,30230,2)
 ;;=^5003353
 ;;^UTILITY(U,$J,358.3,30231,0)
 ;;=F16.159^^120^1540^7
 ;;^UTILITY(U,$J,358.3,30231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30231,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,30231,1,4,0)
 ;;=4^F16.159
 ;;^UTILITY(U,$J,358.3,30231,2)
 ;;=^5003331
 ;;^UTILITY(U,$J,358.3,30232,0)
 ;;=F16.259^^120^1540^8
 ;;^UTILITY(U,$J,358.3,30232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30232,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic D/O w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,30232,1,4,0)
 ;;=4^F16.259
 ;;^UTILITY(U,$J,358.3,30232,2)
 ;;=^5003344
 ;;^UTILITY(U,$J,358.3,30233,0)
 ;;=F16.959^^120^1540^9
 ;;^UTILITY(U,$J,358.3,30233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30233,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,30233,1,4,0)
 ;;=4^F16.959
 ;;^UTILITY(U,$J,358.3,30233,2)
 ;;=^5003356
 ;;^UTILITY(U,$J,358.3,30234,0)
 ;;=F16.99^^120^1540^17
 ;;^UTILITY(U,$J,358.3,30234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30234,1,3,0)
 ;;=3^Hallucinogen Related D/O,Unspec
 ;;^UTILITY(U,$J,358.3,30234,1,4,0)
 ;;=4^F16.99
 ;;^UTILITY(U,$J,358.3,30234,2)
 ;;=^5133359
 ;;^UTILITY(U,$J,358.3,30235,0)
 ;;=F16.983^^120^1540^16
 ;;^UTILITY(U,$J,358.3,30235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30235,1,3,0)
 ;;=3^Hallucinogen Persisting Perception D/O
 ;;^UTILITY(U,$J,358.3,30235,1,4,0)
 ;;=4^F16.983
 ;;^UTILITY(U,$J,358.3,30235,2)
 ;;=^5003358
 ;;^UTILITY(U,$J,358.3,30236,0)
 ;;=F16.21^^120^1540^20
 ;;^UTILITY(U,$J,358.3,30236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30236,1,3,0)
 ;;=3^Hallucinogen Use DO,Mod/Sev,In Remiss
 ;;^UTILITY(U,$J,358.3,30236,1,4,0)
 ;;=4^F16.21
 ;;^UTILITY(U,$J,358.3,30236,2)
 ;;=^5003337
 ;;^UTILITY(U,$J,358.3,30237,0)
 ;;=F16.11^^120^1540^18
 ;;^UTILITY(U,$J,358.3,30237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30237,1,3,0)
 ;;=3^Hallucinogen Use DO,Mild,In Remiss
 ;;^UTILITY(U,$J,358.3,30237,1,4,0)
 ;;=4^F16.11
 ;;^UTILITY(U,$J,358.3,30237,2)
 ;;=^268239
 ;;^UTILITY(U,$J,358.3,30238,0)
 ;;=F11.10^^120^1541^25
 ;;^UTILITY(U,$J,358.3,30238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30238,1,3,0)
 ;;=3^Opioid Use DO,Mild,Uncomp
 ;;^UTILITY(U,$J,358.3,30238,1,4,0)
 ;;=4^F11.10
 ;;^UTILITY(U,$J,358.3,30238,2)
 ;;=^5003114
 ;;^UTILITY(U,$J,358.3,30239,0)
 ;;=F11.129^^120^1541^22
 ;;^UTILITY(U,$J,358.3,30239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30239,1,3,0)
 ;;=3^Opioid Intox w/o Perceptual Dists w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,30239,1,4,0)
 ;;=4^F11.129
 ;;^UTILITY(U,$J,358.3,30239,2)
 ;;=^5003118
 ;;^UTILITY(U,$J,358.3,30240,0)
 ;;=F11.14^^120^1541^5
